ELECTROCHEMICAL OXYGEN CONCEPTS INC

Profile

Company Names

ELECTROCHEMICAL OXYGEN CONCEPTS INC

Addresses

12500 NETWORK BLVD., SUITE 310, SAN ANTONIO, TX 78249

2 AMBER GLEN, SAN ANTONIO, TX 78257

Phone Numbers

210-338-7300
210-698-1562

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$22,086,522.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2022-09-28 
$370,000.00 
$370,000.00 
$0.00 
Equity 
11
2021-01-21 
$500,000.00 
$500,000.00 
$0.00 
Equity 
10
2020-11-02 
$500,000.00 
$500,000.00 
$0.00 
Equity 
9
2020-08-19 
$500,000.00 
$500,000.00 
$0.00 
Equity 
8
2019-08-19 
$2,300,000.00 
$2,300,000.00 
$0.00 
Equity, Debt 
7
2018-05-03 
$8,710,820.00 
$8,710,820.00 
$0.00 
Equity, Debt 
6
2017-07-07 
$907,500.00 
$907,500.00 
$0.00 
Debt 
5
2014-04-01 
$70,000.00 
$70,000.00 
$0.00 
Equity 
4
2011-08-29 
$4,290,702.00 
$4,500,000.00 
$209,298.00 
Equity 
3
2010-05-13 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
2
2009-07-31 
$705,000.00 
$705,000.00 
$0.00 
Equity 
1
2009-04-01 
$732,500.00 
$732,500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TED 
M. 
BUCHTER 
DIRECTOR
JAMES 
W. 
DEYOUNG 
DIRECTOR
DR. LANNY 
 
GEARY 
DIRECTOR
DAVID 
J. 
KAZYNSKI 
DIRECTOR
LEE 
M. 
KELLEY 
EXECUTIVE OFFICER
JOSEPH 
 
MOFFETT 
EXECUTIVE OFFICER, DIRECTOR
MARK 
Q. 
NIEDERAUER 
EXECUTIVE OFFICER, DIRECTOR
JIM 
W. 
PHILLIPS 
DIRECTOR
L. 
PETER 
SMITH 
DIRECTOR
MICHAEL 
WELLS 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
C. 
WELLS 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2019-08-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2018-05-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-07-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GORDIAN INVESTMENTS, LLC